Labiotech.eu - Europe's leading Biotech News Website

From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah

How to Invest Smart in Biotech Stocks

Why Are There Only 10 Cell and Gene Therapies in Europe?

Gene & Cell therapy

Latest News

Medical
25/09/2020
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Brain
22/09/2020
Compass Pathways’ IPO Highlights UK’s Lead in Psychedelics
Medical
17/09/2020
3D Bioprinting Gains a Foothold in Biomedicine
Cancer
16/09/2020
Cancer Research Heats up with Biotechs Attacking Tumor ‘Comfort Zone’
Cancer
14/09/2020
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
Industrial
10/09/2020
The Evolving Arsenal Against Mosquito-Borne Diseases
Food
08/09/2020
Investor Interest in Meat Alternative Biotechs Booms

Trending This Month

A Renaissance in Chronic Kidney Disease Treatment Is Underway

Investor Interest in Meat Alternative Biotechs Booms

Investor Interest in Meat Alternative Biotechs Booms

After Years of Neglect, Algae Biotechnology Makes a Comeback

After Years of Neglect, Algae Biotechnology Makes a Comeback

T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors

T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors

This category can only be viewed by members. To view this category, sign up by purchasing Labiotech Insider Yearly Membership, Labiotech Insider Company Yearly Membership or Labiotech Insider Monthly Membership.

How to Invest Smart in Biotech Stocks

Member Exclusive

This category can only be viewed by members. To view this category, sign up by purchasing Labiotech Insider Yearly Membership, Labiotech Insider Company Yearly Membership or Labiotech Insider Monthly Membership.

Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur

Member Exclusive

Why a US Presence Can Help European Biotechs Get Ahead

Member Exclusive

More Exclusive Content

Refresh Virtual: Immuno-oncology - The Investor's Perspective

What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies?

Sponsored by

How a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring

Sponsored by

Biotech Money Insider 2020 - Available Now For Insider Members

Content First: Labiotech’s Vision for 2020 and Beyond

Follow our Coverage of the Coronavirus